Skip to main content

Boteraser | Website and Server Security Solutions

🛡️ CVE-2025-20177 — ios-xr

🟡 CVSS 6.7 — Medium ✅ No Known Exploit CWE-274 NVD
6.7
CVSS Score
0 Low4 Medium7 High9 Critical10

Description

A vulnerability in the boot process of Cisco IOS XR Software could allow an authenticated, local attacker to bypass Cisco IOS XR image signature verification and load unverified software on an affected device. To exploit this vulnerability, the attacker must have root-system privileges on the affected device.

This vulnerability is due to incomplete validation of files in the boot verification process. An attacker could exploit this vulnerability by manipulating the system configuration options to bypass some of the integrity checks that are performed during the boot process. A successful exploit could allow the attacker to control the boot configuration, which could enable them to bypass the requirement to run Cisco-signed images or alter the security properties of the running system.

Note: Because exploitation of this vulnerability could result in the attacker bypassing Cisco image verification, Cisco has raised the Security Impact Rating (SIR) of this advisory from Medium to High.

How this vulnerability can be exploited

This issue can be reached with local access to the system, attack complexity is low, an attacker needs administrative privileges on the target. No user interaction is required. The scope is unchanged, so the impact stays within the vulnerable component. Rated impact: confidentiality high, integrity high, availability high.

CVSS metrics in full

The score comes from this vector: CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H

  • Attack vector: Local — a local account, shell or session on the host is needed.
  • Attack complexity: Low — the attack works reliably, with no preparation.
  • Privileges required: High — administrative rights are needed first.
  • User interaction: None — nobody has to be tricked into anything.
  • Scope: Unchanged — the damage stays inside the vulnerable component.
  • Confidentiality impact: High — total loss, or loss the attacker controls.
  • Integrity impact: High — total loss, or loss the attacker controls.
  • Availability impact: High — total loss, or loss the attacker controls.

Weakness class

CVE-2025-20177 is classified as CWE-274: Improper Handling of Insufficient Privileges. The product does not handle or incorrectly handles when it has insufficient privileges to perform an operation, leading to resultant weaknesses.

Affected software

CVE-2025-20177 is recorded against 1 package.

  • ios-xr

Timeline and source

Published on 12 March 2025 and last revised on 17 June 2026. No public exploit is currently recorded for this entry. Record sourced from NVD.

References

blog.apnic.net
sec.cloudapps.cisco.com

Other advisories for this package

ios-xr has other advisories on record. If you are patching this one, these are worth checking on the same host:

Same weakness in other software

These advisories are the same class of weakness (CWE-274: Improper Handling of Insufficient Privileges) in other software:

Details

Severity MEDIUM
CVSS Score 6.7
CVSS Vector CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H
CWE CWE-274
Public Exploit ✅ No
Source NVD
Published 2025-03-12
Updated 2026-08-20
Modified 2026-06-17
Fix URL N/A

Affected Packages

Software From version Fixed in
ios-xr

Similar Threats

Vulnerability Monitoring

Track new vulnerabilities in ios-xr

CVE-2025-20177 is rated CVSS 6.7 Medium. BotEraser monitors your WordPress installation and notifies you when software you use appears in our vulnerability database.

Set Up Free Alerts →

No credit card required  ·  Results in minutes

ⓘ Data Notice: The information presented above has been compiled from publicly available internet sources. Boteraser aggregates this data solely for informational purposes and does not independently classify, evaluate, or endorse any findings about the vulnerabilities listed. The accuracy and completeness of this information is the sole responsibility of the original publishers. Boteraser and its operators accept no liability for any decisions made based on this data.

Browse related advisories

All advisoriesCVECVE 2025